Existing data suggest a genetic association between the met 158 allele of catechol-Omethyltransferase (COMT) and obsessive-compulsive disorder (OCD). However, the results are inconclusive and complicated by possible gender differences. We sought to resolve the question in two ways. First, we carried out a new case-control study in 87 adults with OCD and 327 healthy comparison subjects. The study replicated reports of an increased met 158 allele frequency in men with OCD (odds ratio (OR) = 1.91, 95% confidence interval (CI) 1.07-3.40, P = 0.026), with no effect in women (OR = 1.13, 95% CI 0.74-1.72, P = 0.56). Second, we performed a meta-analysis of all published case-control data (n = 1908 subjects). This revealed an association of COMT met 158 with OCD (OR = 1.23, 95% CI 1.06-1.42, P = 0.005) and an interaction with gender (z = 4.27, P < 0.0001). The association between COMT met 158 and OCD was present in men (OR = 1.88, 95% CI 1.45-2.44, P < 0.001) but not in women (OR = 0.98, 95% CI 0.78-1.22, P = 0.83). We conclude that COMT may play a role in the genetic aetiology of OCD in men. The biological plausibility of the association is increased by the functionality of the val 158 met polymorphism in terms of its effect on COMT enzyme activity, and by the role of COMT in cortical dopamine signalling and information processing. The finding also extends the evidence for sexual dimorphism in COMT and in OCD.
Introduction
COMT metabolizes catechols, including dopamine, norepinephrine and catecholestrogens. 1, 2 The human COMT gene contains a common single nucleotide polymorphism (SNP), a G to A missense variant, which encodes either valine (val) or methionine (met) at codon 158. 3 The val 158 met SNP has been associated with a range of psychiatric phenotypes, as well as with the performance and efficiency of cortical information processing in domains including working memory, emotional reactivity and pain responses. [4] [5] [6] These effects are thought to reflect the impact of COMT upon dopamine metabolism and signalling, 7, 8 and its modulation by the val 158 met SNP. 6, [9] [10] [11] Importantly, the SNP is functional, 3 with met-COMT having a 30% lower enzyme activity in human brain compared to val-COMT. 12 Thus, genetic associations with the val 158 met allele are likely to be direct, and can be interpreted with regard to the known biology of COMT.
Obsessive-compulsive disorder (OCD) is a familial disorder with a heritable component. 13 The genetic architecture, chromosomal loci and susceptibility genes are unclear, but the postulated pathophysiological involvement of monoamines 14, 15 has led to association studies with serotonergic and dopaminergic candidate genes. Positive findings have been reported for several genes, particularly the serotonin 2A receptor (HTR2A), monoamine oxidase A (MAOA) and COMT, but results remain inconclusive. One complicating factor is that gender differences are relatively common in genetic studies of OCD, perhaps contributing to the differing clinical phenotype between the sexes, whereby males have an earlier age of onset, more comorbid tics and poorer outcome. 16 For example, HTR2A shows association with OCD primarily in women, 17 whereas MAOA 18 and COMT [19] [20] [21] have been associated with OCD in men, albeit one study found association with COMT in women. 22 However, it is always the COMT met 158 allele that is associated with OCD. Here we report an additional case-control study of COMT val 158 met in OCD and provide a meta-analysis of the literature. The results provide support for the association of the met 158 allele of COMT with OCD, but only in men. 
Materials and methods

Case
Genotyping
Two buccal swabs per person were taken. DNA was extracted using a DNA Spin Cell Culture Kit (Bioline, UK). DNA yield varied from 3 to 7 mg per swab; sample purity was > 1.7 OD units. Primer extension preamplification (PEP) was used, as described, to increase DNA yields from the swabs. 23 In pilot studies, 200 DNA samples were genotyped before and after PEP, and there were no discrepancies.
Primers ( ), as shown in Figure 1 . Cases and controls were genotyped at the same time. Gels were scored, blind to diagnosis, independently by two researchers. Any equivocal results were resolved by repeat genotyping. w 2 analyses were performed, on men and women combined, and separately, given the previous reports of sexual dimorphism of the COMT val 158 met association with OCD.
Meta-analysis
For the meta-analysis, all published case-control studies of the COMT val 158 met polymorphism in OCD were identified via a Medline search, using the query terms '(COMT OR catechol-O-methyl*) AND (OCD or obsessive-compulsive)'. Additionally, reference lists of these and other relevant articles were manually searched. The final search was performed on 30 October 2006. Heterogeneity, publication bias, sensitivity analysis and Rosenthal's failsafe N were all determined. As with the case-control study, the metaanalysis was performed for the whole data set and for men and women separately. Meta-analytic procedures were carried out using Comprehensive Meta-Analysis v.2.0 (Biostat Inc., Englewood, NJ, USA; www.metaanalysis.com), except for the investigation of gender, which used sbe23 in Stata 9.1.
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Results
Case-control study Our case-control study showed a trend association between the COMT met 158 allele and OCD (OR = 1.37, 95% CI = 0.98-1.92; w 2 = 3.33, df = 1, P = 0.069). The association was significant in men (OR = 1.91, 95% CI = 1.07-3.40; w 2 = 4.97, df = 1, P = 0.026), but not in women (OR = 1.13, 95% CI = 0.74-1.72, w 2 = 0.33, df = 1, P = 0.56). OCD and control groups were in Hardy-Weinberg equilibrium (both P > 0.25).
Meta-analysis
Sixteen studies were identified, of which eight, including the current one, met criteria for inclusion in the meta-analysis. [19] [20] [21] [25] [26] [27] [28] See Supplementary Information for details of the omitted studies. The individual included studies contained 17-155 OCD cases and 54-327 controls, totalling 606 subjects with OCD and 1302 controls (Table 1) . Genotypes in all case and control groups were in Hardy-Weinberg equilibrium. There was no heterogeneity between studies (Q = 7.09, df(Q) = 7, P = 0.419; men only: Q = 5.07, df(Q) = 4, P = 0.280; women only: Q = 1.90, df(Q) = 4, P = 0.75), and a fixed effects model was used; as would be anticipated, virtually identical results were obtained under a random-effects model ( Figure 2) .
The meta-analysis showed association of OCD with the COMT met 158 allele (OR = 1.23, 95% CI = 1.06-1.42; Z = 2.81, P = 0.005; Figure 2a ). Meta-regression indicated that there was an interaction of this effect with gender (Z = 4.27, P < 0.0001). Meta-analysis of data in men and women separately revealed an association with OCD in men (OR = 1.86, 95% Figure 2c) , and with non-overlapping confidence intervals between the two genders. The only study not to find a significant association in men 26 ( Figure 2b ) was the smallest ( Table 2) .
The association of COMT met 158 with OCD remained significant after removal of any one study (see table in Supplementary Information); this includes omission of the original report 19 (residual OR for men and women combined = 1.17, 95% CI = 1.00-1.36, Z = 1.96, P = 0.049; residual OR for men = 1.68, 95% CI = 1.25-2.25; Z = 3.49, P = 0.003). The Rosenthal failsafe N is 22 studies (men) and 7 studies (men and women combined). Funnel plots did not indicate evidence of publication bias (see figure in Supplementary Information).
Discussion
The result of our case-control study replicates three earlier findings of an association between the met 158 allele of COMT and OCD in men. [19] [20] [21] Although a replication, our study was small and of itself only modestly extends the prior evidence. However, our meta-analysis provides significant evidence associating the met 158 allele of COMT with OCD (Figure 2a ), and specifically with OCD in men (Figure 2b) . The results are statistically robust, and show a reasonably large odds ratio, by the standards of most comparable meta-analyses in psychiatric genetics, including the putative associations of the same SNP with schizophrenia 29 and with attention-deficit hyperactivity disorder. 30 The clear effect of the val 158 met allele on COMT activity 3, 12 provides biological plausibility, and increases the prior probability that the association is genuine compared to associations with SNPs of no known function. [31] [32] [33] As such, the candidacy of COMT as a susceptibility gene for OCD is relatively, perhaps unexpectedly, strong, and has substantially advanced since the equivocal positive result of the earlier meta-analysis, which was based on 144 OCD cases and 337 controls. 34 In terms of mechanism, an involvement of COMT in OCD likely reflects its role in modulation of cortical dopamine metabolism, although its role in methylation of other substrates, including catecholestrogens, should be noted. 2 We assume that the association of the met 158 allele with OCD reflects the lower enzyme activity of met-COMT 12 and the consequent enhancement of cortical dopamine signalling, relative to val-COMT. Bilder et al. 9 postulate that the met 158 allele, via its effect on tonic versus phasic dopamine transmission, predisposes to the stability of mental representations and thence the maintenance of particular patterns of thought and behaviour. Several lines of evidence support this proposal. Compared to val-COMT, met-COMT individuals perform less well on tests of task shifting, 35 have an electrophysiological profile indicative of increased stability (but decreased flexibility) of prefrontal neural processing, 36 and show a greater amygdala-orbitofrontal connectivity in response to negative emotional stimuli that is suggestive of inflexible emotional processing. 37 It may be speculated that the stability and relative inflexibility of neural processing associated with met-COMT can become excessive, and thereby render the individual vulnerable to obsessions and compulsions. In terms of anatomy, although COMT functionality is thought to be predominantly cortical, 6 the val 158 met polymorphism also influences striatal dopamine activity, 38, 39 and can thus influence, at both cortical and subcortical levels, signalling within the corticostriatal loops that underlie the pathophysiology of OCD. 40, 41 There are gender differences in genetic architecture for many complex traits, 42 and sex-specific genetic 43 and association studies. [17] [18] [19] However, to our knowledge, the present meta-analysis is the first convincing evidence for an individual SNP or gene contributing sex-specific risk for OCD, or any other psychiatric disorder. It is noteworthy that COMT is a gene for which there is already diverse evidence for sexual dimorphism. For example, the neurochemical and behavioural phenotype differs between male and female COMT knockout mice, 7 COMT enzyme activity in human brain is higher in women than men, 12 and the val 158 met allele has opposing effects on prefrontal cortex morphology in men and women with velocardiofacial syndrome. 44 The basis for, and implications of, these gender differences are poorly understood. They may relate, in part at least, to the regulation of COMT expression by estrogens, 45 and to sex differences in other dopaminergic parameters and dopamine-related disorders. 46 These considerations emphasize that gender should be taken fully into account in investigations of COMT and in studies of the genetic basis of OCD.
Despite the evidence presented here, further data are needed before COMT could be considered unequivocally an OCD susceptibility gene. The combined sample size, although now over 1900 subjects, is still not large, and the limited family-based studies provide inconclusive evidence for the association. 34 Thus, additional studies, of both designs, are needed. 47 Finally, although the val 158 met SNP is the main genetic influence upon COMT function, the COMT locus contains additional SNPs (not yet studied in OCD) that modulate the val 158 met effect. 6, 48, 49 We speculate that it is the haplotypes associated with the lowest COMT activity, and thereby the most 'supra-optimal' cortical dopamine signalling, that confer the greatest OCD risk.
